AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 221 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $283,795 | +23.8% | 10,021 | +0.4% | 0.00% | – |
| Q1 2023 | $229,241 | -19.0% | 9,980 | -0.9% | 0.00% | – |
| Q4 2022 | $282,850 | +23.5% | 10,073 | +24.8% | 0.00% | – |
| Q3 2022 | $229,000 | -95.1% | 8,070 | -92.1% | 0.00% | -100.0% |
| Q4 2018 | $4,689,000 | +5.9% | 101,700 | +77.2% | 0.00% | +50.0% |
| Q3 2018 | $4,427,000 | -8.4% | 57,400 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $4,835,000 | +3.0% | 57,400 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $4,694,000 | +31.4% | 57,400 | -8.2% | 0.00% | 0.0% |
| Q4 2017 | $3,573,000 | -17.7% | 62,500 | -3.8% | 0.00% | 0.0% |
| Q3 2017 | $4,339,000 | -80.3% | 65,000 | -81.9% | 0.00% | -80.0% |
| Q3 2014 | $22,000,000 | +10.0% | 358,600 | -17.8% | 0.01% | +11.1% |
| Q2 2014 | $20,000,000 | +6.8% | 436,500 | -8.7% | 0.01% | 0.0% |
| Q1 2014 | $18,725,000 | +55.9% | 478,300 | -4.6% | 0.01% | +50.0% |
| Q4 2013 | $12,011,000 | -31.7% | 501,500 | -20.3% | 0.01% | -33.3% |
| Q3 2013 | $17,598,000 | – | 629,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |